Published on in Vol 11, No 10 (2022): October
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/37452, first published
.

Journals
- Deinichenko O, Sіusіuka V, Krut’ Y, Pavlyuchenko M, Puchkov V, Shevchenko A, Kolokot N. Clinical and pathogenetic mechanisms of formation of fetal growth retardation. Reproductive health of woman 2023;(3):24 View
- Palmrich P, Kalafat E, Pateisky P, Schirwani‐Hartl N, Haberl C, Herrmann C, Khalil A, Binder J. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction. Ultrasound in Obstetrics & Gynecology 2024;63(5):619 View
- Ramirez Zegarra R, Ghi T, Lees C. Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo. European Journal of Obstetrics & Gynecology and Reproductive Biology 2024;300:268 View
- Garcia-Manau P, Bonacina E, Martin-Alonso R, Martin L, Palacios A, Sanchez-Camps M, Lesmes C, Hurtado I, Perez E, Tubau A, Ibañez P, Alcoz M, Valiño N, Moreno E, Borrero C, Garcia E, Lopez-Quesada E, Diaz S, Broullon J, Teixidor M, Chulilla C, Ferrer-Costa R, Gil M, Lopez M, Ramos-Forner G, Blanco J, Moreno A, Lázaro-Rodríguez M, Vaquerizo O, Soriano B, Fabre M, Gomez-Valencia E, Cuiña A, Alayon N, Sainz-Bueno J, Vives A, Esteve E, Ocaña V, López M, Maroto A, Carreras E, Mendoza M. Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial. Nature Medicine 2025;31(3):1008 View
- Bartels H, Hobson S. The Role of Angiogenic Factors in Fetal Growth Restriction. Clinical Obstetrics & Gynecology 2025;68(4):545 View
- Tiwari K, Nizamudeen J, Jagadeesan P. Study on clinical profile, risk factors, morbidity and mortality pattern on intrauterine growth restricted babies admitted in sick newborn care unit in tertiary care hospital GRMCH, Ramanathapuram. International Journal of Contemporary Pediatrics 2026;13(8):1414 View
